Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Journal of Neuromuscular Diseases|October 31, 2022
Gene Therapy for Neuromuscular Diseases: Health Economic Challenges and Future PerspectivesErik Landfeldt
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 1, 2021
Rasch Analysis of the Pediatric Quality of Life Inventory 4.0 Generic Core Scales Administered to Patients With Duchenne Muscular DystrophyErik Landfeldt, Joel Iff, Erik Henricson, et al.
Bone|September 21, 2010
The societal burden of poor persistence to treatment of osteoporosis in SwedenErik Landfeldt, Jonas Lundkvist, Oskar Ström
Applied Health Economics and Health Policy|August 15, 2018
Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good MethodErik Landfeldt, Niklas Zethraeus, Peter Lindgren
Acta Paediatrica (Oslo, Norway : 1992)|September 7, 2018
A mini-review and implementation model for using ataluren to treat nonsense mutation Duchenne muscular dystrophyErik Landfeldt, Thomas Sejersen, Már Tulinius
Journal of Neuromuscular Diseases|November 11, 2017
Patient Preferences for Treatments of Neuromuscular Diseases: A Systematic Literature ReviewErik Landfeldt, Josefin Edström, Peter Lindgren, et al.
Developmental Medicine and Child Neurology|June 16, 2018
Duchenne muscular dystrophy and caregiver burden: a systematic reviewErik Landfeldt, Josefin Edström, Filippo Buccella, et al.
Pageof 5